Admission Date:  [**2161-1-16**]              Discharge Date:   [**2161-2-21**]  Date of Birth:  [**2100-10-31**]             Sex:   M  Service: MEDICINE  Allergies: Metoprolol / Ibuprofen  Attending:[**First Name3 (LF) 2641**] Chief Complaint: Hemoptysis  Major Surgical or Invasive Procedure: Bronchoscopy [**2161-1-17**]  History of Present Illness: 60 year old man with metastatic NSCLC (R hilar mass) s/p chemotherapy (Navelbine) and completed course of radiation, also membranous nephropathy, CAD, schizophrenia, and COPD who is transferred from micu after presenting with hemoptosis from [**Hospital **] rehab.
In the MICU his hemoptysis resolved, hct remained stable, no transfussion required.
He had a bronchoscopy [**1-18**] that showed his right hilar mass but no stigmata of bleeding.
He was treated for COPD exacerbation with z-pak (started [**1-18**]) and prednisone taper.
Of note, He was recently admitted to [**Hospital1 18**] [**2160-11-27**]- [**2160-12-27**] with a pathologic fracture of his left femur which was treated with radiation.
His course was complicated by hospital acquired pneumonia (sputum grew pseudomonas), treated with a 2 week course of Zosyn, followed by a two week course of Ceftaz which was started b/c he was hypotensive and repeat sputum culutres grew sparse GNRs and oropharyngeal flora.
Currently he has no complaints.
He denies visual changes, hearing changes, congestions, sore throat, chest pain, nausea, vomitting, abdominal pain, shortness of breath, dysuria, melena, BRBPR, leg pain other than left hip (which currently is not painful), back pain, tingling or numbness.
Past Medical History: Non-small-cell lung cancer, metastatic left femur fx, [**11/2160**], had lytic lesion and then fell on [**Hospital Ward Name 1826**] 7 Arterial embolic disease s/p right SFA stent in [**June 2159**] CAD s/p 2 vessel CABG at [**Hospital1 112**] in [**Month (only) 205**] 97 HTN COPD CHF; EF 35-40% Hypercholesterolemia Primary polydipsia BPH s/p TURP Schizophrenia, Paranoia Nephrotic Syndrome [**2-28**] membranous GN  Social History: He did smoke for 30 years, but quit.
He previously was in the real estate business with his brother.
Family History: Mother died at age 60 of cancer (unknown type)  Physical Exam: VS: T 97.7, BP 126/77, HR 99, RR 18, 100% 2L Gen: comfortable, no apparent distress HEENT: perrl, eomi Neck: no JVD Lungs: b/l course rhonchi Heart: RRR nl S1S2 no M/R/G Abd: soft, ND/NT, no rebound or guarding Ext: LE muscle wasting, 2+ DP pulses.
clear lungs otherwise, w/o evidence pleural effusions  Bronchoscopy - showed no evidence of intrinsic compression, no evidence of active or prior evidence of bleeding.
Hemoptysis:  This was felt to be most likely secondary to NSCLC with R hilar mass.
He had a bronch on [**2161-1-17**] that showed no stigmata of current or recent bleeding.
He continued to have intermittent blood-tinged sputum during this hospitalization.
They recommended IR guided embolization if hemoptysis were to persist.
COPD Flare: The patient had a productive cough and was wheezing throughout his hospital course.
Dysuria:  He had intermittent dysuria throughout this hospital course.
A renal US on [**2-18**] was done to further evaluate for potential post-obstructive picture and was normal.
Bladder scans were also done to rule out urinary retention as a potential cause of his dysuria.
For symptomatic relief he was also started on pyridium as well.
Left femur fx: Medically managed throughout the hospital course, given that he is a poor surgical candidate.
His pain was managed with oxycontin, lidocaine patch and oxycodone prn.
On [**2161-2-13**], he reported having worsening left lower extremity pain and worsening swelling at the level of the hip.
A CT scan of the hip revealed further dislocation of the femur and increased hematoma.
He did have urine cultures postive for coag negative staph and was started on macrobid.
Chest pain:  On [**2161-2-18**], began to report right sided chest pain near port.
No evidence of infection.
Cx-ray revealed proper placement of port and no evidence of rib fractures.
His EKG was without acute ischemic changes.
His pain was managed with oxycodone prn.
CKD: Pt has history of membranous nephropathy associated with malignancy.
However due to subsequent hypotensive episodes to the 80s resolving with hydration, his antihypertensives were discontinued.
CAD s/p CABG: The patients aspirin was held in the setting of hemoptysis but was restarted prior to discharge.
Hypothyroidism: continued levothyroxine at home dose   Medications on Admission: Lidoderm patch qdaily Acetaminophen prn Fluticasone-Salmeterol 250-50 1 puff [**Hospital1 **] Ipratropium Bromide 1 puff QID Levothyroxine 25 mcg daily Pravastatin 20 mg daily Prednisone 20 mg daily Protonix 40mg daily Lisinopril 5mg daily Calcium Carbonate 500 mg PO QID Olanzapine 10 mg PO QAM, 20mg PO QPM Fluphenazine HCl 10 mg PO QAM, 15mg QPM Lorazepam 2 mg PO TID at 0900, 1400, 1800 Trazodone 50 mg QHS prn Xopenex neb QID Colace 100 mg PO BID Senna 8.6 mg PO BID prn Bisacodyl 10mg po prn Bactrim 160-800 mg Tablet, 1 tab PO 3X PER WEEK Insulin SS Oxycodone 5 mg Tablet  PO Q4H prn pain Oxycontin 20mg PO Q12H Nitroglycerin SL prn Aspirin 81mg daily Xenaderm oint to sacral wound qShift   Discharge Medications: 1.
Trazodone 50 mg Tablet Sig: One (1) Tablet PO at bedtime as needed for sleep.
Senna 8.6 mg Capsule Sig: One (1) Capsule PO twice a day as needed for constipation.
Clindamycin Phosphate 1 % Solution Sig: One (1) Appl Topical DAILY (Daily) as needed for facial acne.
Benzoyl Peroxide 10 % Gel Sig: One (1) Appl Topical DAILY (Daily) as needed for lesions on face, back.
Discharge Disposition: Extended Care  Facility: [**Hospital3 7**] & Rehab Center - [**Hospital1 8**]  Discharge Diagnosis: Hemoptysis Chronic Obstructive Pulmonary Disease Non-small Cell Lung Cancer Coronary Artery Disease   Discharge Condition: Improved; oxygenating well on RA.
You had a bronchoscopy to look into your lungs and they did not see any evidence of bleeding.
You also had a cough and wheezing.
Please alert your medical provider if you have any further blood when you cough, lightheadedness or any symptoms that are new or of concern to you.
You were advised of the potential risks of further bleeding due to your underlying malignancy, especially in the setting of  blood thinner (to prevent blood clots) and kidney disease.
